A combined treatment for advanced oral cavity cancers

Cancer

Volumn 62, Issue 7, 1988, Pages 1267-1274

  Olasz, Lajos ^a   Szabo, Imre ^a   Horvath, Anna ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FOLINIC ACID; METHOTREXATE; MITOLACTOL; PREDNISONE; VINCRISTINE;

AGE; CLINICAL ARTICLE; HISTOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUTH CANCER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ACTUARIAL ANALYSIS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMAN; MIDDLE AGE; MOUTH NEOPLASMS; NEOPLASM STAGING; REMISSION INDUCTION;

EID: 0023713975     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19881001)62:7<1267::AID-CNCR2820620704>3.0.CO;2-G     Document Type: Article

References (33)

1. Radiation therapy for head and neck cancers
2. Fast neutron teletherapy for advanced carcinomas of the oral cavity and soft palate
3. Carcinoma of the oral tongue and floor of mouth: Fifteen years' experience with linear accelerator therapy
4. Therapie von Karzinomen der Gingiva: Erfahrungen mit Radiotherapie und kombinierter Therapy bei 88 Patienten aus dem Zeitraum 1950‐bis 1976
5. Orientation générale du traitement des carcinomes della cavité buccale et de l' oropharynx
6. The role of initial modality in treatment of squamous cell carcinoma of the tongue
7. Surgery versus combined therapies for cancer of the anterior floor of the mouth
8. Carcinoma of the tongue: Evaluation of surgical treatment of 123 cases
9. The use of hyperbaric oxygen therapy in bony reconstruction of the irradiated and tissue‐dificient patient
10. VBM chemotherapy before curietherapy in the treatment of T2 oral carcinomas
11. Results of a low‐dose combination chemotherapy with vincristine, bleomycin and methotrexate (V‐B‐M): Based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma
12. The chemotherapy of head and neck cancer
13. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx and hypopharynx
14. Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions
15. Improved results in combination chemotherapy of head and neck cancer using a kinetically‐based approach: A randomised study with and without Adriamycin
16. Cis‐platinum induction chemotherapy in the multimodality initial treatment of advanced Stage IV carcinoma of the head neck
17. Combination of cis‐platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck
18. Combination chemotherapy with cisdiammine‐dichloro‐platinum, Oncovin, and bleomycin (COB) in advanced head and neck cancer
19. Bleomycin infusion followed by cyclophosphamide, methotrexate, and 5‐fluorouracil in advanced squamous carcinoma of the head and neck
20. Improved complete response rate and survival in advanced head and neck cancer after three‐course induction therapy with 120‐hour 5‐FU infusion and cisplatin
21. Impact of primary site of Stage III and IV squamous cell carcinomas of the head and neck on 7‐year survival figures following initial noncisplatin‐containing combination chemotherapy
22. Salvage of Stage IV intraoral squamous cell carcinomas with preoperative 5‐fluorouracil
23. Sequential methotrexate and 5‐fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck
24. The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin‐containing combination chemotherapy
25. Analysis of mortality and morbidity in 100 composite resections for oral carcinoma
26. Myocutaneous flaps for head and neck reconstruction
27. Cell kinetical analysis of squamous cell carcinomas of the oral region and the effect of a combined therapy of 5‐fluorouracil and irradiation: A contribution to the discussion about tumour cell‐syncronization
28. An experimental biological basis for increasing the therapeutic index of clinical cancer therapy
29. Langzeitergebnisse der synchronisierten Radiotherapie bei inoperablen orofazialen Plattenepithelkarzinomen
30. Gyógyszerkombinációk ósszeállitásának elvi alapjai a daganatkemoterápiaban
31. Bleomycin is a possible syncronizing agent for human tumor cells in vivo
32. Phase II study of dibromodulcitol
33. Definitive treatment of extended planocellular cancers of the oral cavity by preoperatively administered antineoplastic agents